跳至主要内容
临床试验/IRCT20090609002017N36
IRCT20090609002017N36尚未招募Unknown

The effect of boron citrate supplementation on the expression of PPAR-?, SIRT1, PGC-1a, and AMPK genes in obese subjects: a double-blind randomized controlled clinical trial

Tabriz University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • Ages between 18 to 60 years
  • body mass index (BMI) 30 to 40 kg/m2
  • Residence in Tabriz

排除标准

  • Consuming alcohol
  • Individuals taking chemical or herbal drugs for weight loss, hepatotoxic drugs, anti-hypertensive drugs, lipid-lowering and anti-diabetic drugs, corticosteroid, and non-steroidal anti-inflammatory drugs and antibiotics.
  • Individuals who are pregnant, lactating, menopause, and those who use birth control pills and estrogen
  • Individuals who have some pathologic conditions such as cardiovascular, liver, thyroid, parathyroid, kidney, gastrointestinal tract and autoimmune diseases as well as suffering from polycystic ovary syndrome, cancer and inflammatory disease
  • Individuals who underwent weight loss surgery in the last year or weight loss diets in the last three months

研究者

相似试验